What is the true risk of a pharmacokinetic drug–drug interaction?

By Fuhr Uwe  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 897-899

Springer Publishing Company

Access to resources Recommend Favorite

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

By Johnson Trevor N.   Boussery Koen   Rowland-Yeo Karen   Tucker Geoffrey T.   Rostami-Hodjegan Amin  

Clinical Pharmacokinetics, Vol. 49, Iss. 3, 2010-03 ,pp. : 189-206

Adis International

Access to resources Recommend Favorite

Integrated Population Pharmacokinetic Model of Both Cyclophosphamide and Thiotepa Suggesting a Mutual Drug–Drug Interaction

By de Jonge Milly E.   Huitema Alwin D. R.   Rodenhuis Sjoerd   Beijnen Jos H.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 2, 2004-04 ,pp. : 135-156

Springer Publishing Company

Access to resources Recommend Favorite

Itraconazole/darunavir/ritonavir interaction: Increased itraconazole plasma levels and increased itraconazole elimination half-life: case report

By  

Reactions Weekly, Vol. 1, Iss. 1403, 2012-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Drug–Drug Interaction of the Novel Anticancer Agent E7070 and Acenocoumarol

By van den Bongard H.J.G. Desirée   Sparidans Rolf W.   Critchley David J.P.   Beijnen Jos H.   Schellens Jan H.M.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite